Product Information
XELJANZ 10 MG TABLET is a brand product labeled by Pfizer Inc., priced at $103.9384 per EA under NDC 00069100201. Its NADAC has been published 118 times since May 22, 2024.
FDA first approved this application on Nov 6, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Pfizer Inc.NDC
00069100201
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TOFACITINIB CITRATEApproval Type
New Drug (NDA)
FDA Application
NDA203214FDA Approved
11/6/2012
TE Code
AB
On Market Since
7/2/2018
Pharmacological Classes
Price Statistics
The NADAC for XELJANZ 10 MG TABLET has been published 118 times since May 22, 2024, and over the history we have for it it has risen 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $103.9384 per EA |
|---|---|
| All-time high | $103.9384 (Aug 19, 2026) |
| All-time low | $93.7324 (Dec 18, 2024) |
| 52-week high | $103.9384 |
| 52-week low | $98.1475 |
| Median price | $98.4191 |
| Average price | $98.6161 |
| Largest weekly change | +5.5% (Dec 31, 2025) |
| Weeks tracked | 118 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tofacitinib market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of XELJANZ 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for XELJANZ 10 MG TABLET, manufactured by Pfizer Inc., is $103.9384 per EA (NDC 00069100201), effective Aug 19, 2026.
How has the price of XELJANZ 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for XELJANZ 10 MG TABLET has risen 10.6%. It has been tracked across 118 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for XELJANZ 10 MG TABLET?
Since May 22, 2024, the NADAC for XELJANZ 10 MG TABLET has ranged from a low of $93.7324 (Dec 18, 2024) to a high of $103.9384 (Aug 19, 2026), with a median of $98.4191 per EA.
Are there cheaper alternatives to XELJANZ 10 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of XELJANZ 10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XELJANZ 10 MG TABLET?
XELJANZ 10 MG TABLET (NDC 00069100201) is labeled by Pfizer Inc., and CMS classifies it as a brand product.